Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM)

CUSIP: 690145107

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
-22,588,349
Put/Call ratio
90%
SEC-reported price per share
$0.68
Indexed holders
76
Value change
-$39,745,792
Number of buys
21
Open additional details 1 more signal available
Number of sells
83
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
18,527,213

Security key

690145107

Report period

Q3 2024

Indexed institutions

76

Top holders

10

Ownership snapshot

Top reported holders of OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AMERIPRISE FINANCIAL INC
Disclosed value leader
AMERIPRISE FINANCIAL INC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $20,020,619 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AMERIPRISE FINANCIAL INC has the largest disclosed position value at $20.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AMERIPRISE FINANCIAL INC's linked filing trail.
Disclosed position value Top 5
AMERIPRISE FINANCIAL INC $20.02M
MORGAN STANLEY $14.69M
JPMORGAN CHASE & CO $11.83M
VANGUARD GROUP INC $10.19M
MILLENNIUM MANAGEMENT LLC $7.48M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AMERIPRISE FINANCIAL INC
13F
Company
13F
—
denominator unverified
$20,020,619
5,200,161 shares
— 30 Jun 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$14,688,789
3,815,270 shares
— 30 Jun 2024
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$11,833,625
3,073,669 shares
— 30 Jun 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$10,187,124
2,646,006 shares
— 30 Jun 2024
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$7,480,161
1,942,899 shares
— 30 Jun 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
13F
—
denominator unverified
$5,924,607
1,538,859 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
76
Shares
26,056,953
Indexed holders
76
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 indexed holders
118
Q3 2024 indexed holders
76
Indexed holder difference
-42
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .